Fractal heterogeneity of peripheral blood flow: Implications for hematogenous metastases

Journal of Surgical Oncology

Volumn 74, Issue 2, 2000, Pages 116-121

  Kendal, Wayne S ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Clustering of metastases; Metastatic potential; Solitary metastases

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FRACTAL ANALYSIS; LUNG BLOOD FLOW; LUNG METASTASIS; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL;

EID: 0033917368     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200006)74:2<116::aid-jso7>3.0.co;2-%23     Document Type: Article

References (34)

1. Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
2. International Registry of Lung Metastases: Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
3. Former JG, Silva JS, Golby RB, et al.: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1984;199:306-316.
4. Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978;38:2651-2660.
5. Barman SA, McCloud LL, Catravas JD, et al.: Measurement of pulmonary blood flow by fractal analysis of flow heterogeneity in isolated canine lungs. J Appl Physiol 1996;81:2039-2045.
6. Grant PE, Lumsden CJ: Fractal analysis of renal cortical perfusion. Invest Radiol 1994;29:16-23.
7. Bassingthwaighte JB, King RB, Roger SA: Fractal nature of regional myocardial blood flow heterogeneity. Circ Res 1989;65: S78-S90.
8. Iversen PO, Nicolayesen G: High correlation of fractals for regional blood flows among resting and exercising skeletal muscles. Am J Physiol 1995;269:H7-H13.
9. Kendal WS, Frost P: Experimental metastasis: a novel application of the variance-to-mean power function. J Natl Cancer Inst 1987; 79:1113-1114.
10. Tokuyama S, Moriya S, Taniguchi S, et al.: Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int J Cancer 1997;73:410-415.
11. Yu H, Schultz M: Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res 1990;50:7623-7633.
12. Di Renzo MF, Bretti S: Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts. Int J Cancer 1982;30:751-757.
13. Hardan I, Weiss L, Hershkoviz N, et al.: Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic ARG-GLY-ASP mimetics. Int J Cancer 1993;55: 1023-1028.
14. Layton MG, Franks LM: Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterization of stable metastatic variants. Br J Cancer 1984;49:415-421.
15. Lollini P-L, Bosco MC, Cavallo F, et al.: Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene. Int J Cancer 1993;55:320-329.
16. Varki NM, Han H, Hamsayeh J, Vu TP: Clones of a spontaneously metastatic human lung carcinoma cell line differ in their in vitro and in vivo phenotypic characteristics. Tumor Biol 1992;13: 237-247.
17. Weiss L, Holmes JC, Ward PM: Do metastases arise from preexisting subpopulations of cancer cells? Br J Cancer 1983;47: 081-089.
18. Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
19. Bradley MO, Kraynak AR, Storer RD, et al.: Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc Natl Acad Sci USA 1986;83:5277-5281.
20. Chambers AF, Hill RP, Ling V: Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells. Cancer Res 1981;41:1368-1372.
21. Chambers AF, Harris JF, Ling V, et al.: Rapid phenotype variation in cells derived from lung metastases of KHT fibrosarcoma. Invasion Metastasis 1984;4:225-237.
22. Dumont JA, Jones WD, Bitoni, AJ: Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res 1992;52:1195-1200.
23. Fidler IJ, Hart IJ: The origin of metastatic heterogeneity in tumors. Eur J Cancer 1981;17:487-494.
24. Fortuna MB, Dewey MJ, Furmansk P: Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett 1990;55:109-114.
25. Harris JF, Chambers AF, Hill RP, et al.: Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor. Proc Natl Acad Sci USA 1982;79:5547-5551.
26. Kozlowski JM, Hart IR, Fidler IJ, et al.: A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 1984;72:913-917.
27. Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 1978;38:2962-2967.
28. Raz A: Regional emergence of metastatic heterogeneity in a growing tumor. Cancer Lett 1982;17:153-160.
29. Zar JH: "Biostatistical Analysis." Englewood Cliffs, NJ: Prentice Hall, 1999.
30. Johnson DL, Petkau AJ: A likelihood ratio test for equality of deviations from randomness. Res Popul Ecol 1995;37:203-209.
31. Nanko M, Shimada H, Yamaoka H, et al.: Micrometastatic colorectal cancer lesions in the liver. Surg Today 1998;28:707-713.
32. Luzzi KJ, MacDonald IC, Schmidt EE, et al.: Multistep nature of metastatic inefficiency. Am J Pathol 1998;153:865-873.
33. Overgaard M, Hansen PS, Overgaard J, et al.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-955.
34. Ragaz J, Jackson SM, Le N, et al.: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-62.